Life science dealmaking is the main focus at BIO-Europe® 2013 to be held in Vienna November 4–6

The 19th annual BIO-Europe®international partnering conference will be held in Vienna, Austria, November 4–6, 2013 at the Messe Wien Exhibition and Congress Center. The fall event is organized by EBD Group in collaboration with local host Life Science Austria Vienna (LISAvienna), the life science cluster of the Republic of Austria and the City of Vienna.

“Vienna’s life science sector is extremely active, in large part due to the strong support of their industry incubator, LISAvienna,” said Florian Schoenhammer, Group Managing Director of EBD Group. “The work of LISAvienna has resulted in the development of a robust cluster that has brought Vienna’s life science innovation to the larger global market. LISAvienna is an ideal partner. We are certain this will be one of our most successful partnering events to date.”

“We are very excited to be working with EBD Group to bring their flagship event to Vienna,” said Johannes Sarx, Managing Director of LISAvienna. “Vienna has a diverse biotech industry and an entrepreneurial culture focused on the development and financing of innovative Austrian life science startups.”

“Vienna is a life science hub due to our central European location, and our research excellence in the areas of infectious disease and vaccines, neurology, respiratory disease and regenerative medicine, among others,” said Peter Halwachs, Managing Director of LISAvienna.

“Vienna is known to many as the ‘city of knowledge’ that draws innovative minds from all over the world, and is considered to be a lucrative business location for international pharmaceutical and biotech companies,” said Renate Brauner, Deputy Mayor of the City of Vienna. “Vienna’s investment in biotech, pharma and medical technology is significant. Since 1998 the city has invested more than EUR 117 million in life science projects. We are proud to host BIO-Europe 2013.”

One-to-one networking opportunities at BIO-Europe in Vienna can be scheduled prior to the event and are facilitated by partneringONE®, EBD Group’s leading conference networking solution. In addition, BIO-Europe delegates participate in program workshops and panels featuring high-level CEOs and industry leaders.

The 2012 edition in Hamburg, Germany was attended by 2,957 delegates representing 52 countries. Delegates had access to 3,028 projects available for partnering, and over 15,000 one-to-one partnering meetings were held.

Information for BIO-Europe can be found online at

Follow BIO-Europe 2013 on Twitter: (hashtag: #BEU13)

Notes to Editors:
Entry to BIO-Europe 2013 is free to members of the press, including full access to the partnering system, sessions, press conferences, workshops, and pre-arranged partnering meetings. Visit the BIO-Europe conference website for registration details.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About BIO-Europe 2013

The 19th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Over 3,000 global decision makers from biotechnology, pharma and finance, representing upwards of 1,700 companies from over 50 countries, annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe will take place November 4–6, 2013 in Vienna, Austria.